Delivery Order 36C24226D0069-36C24226N0631
Award Date 8/24/26
Potential Completion Date 9/30/26
Potential Value $50K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chandler, AZ 85226, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a $300,000 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 16 (VISN 16) on October 30, 2025, for hazardous compounding services. The contract, which carries no set-aside designation and was awarded through full and open competition, will be performed in Chandler, Arizona, with an ultimate completion date of September 30, 2026. Optum Infusion...
- This is a federal contract award for chemo compounding services, valued at $1,071,930.52, awarded to Optum Infusion Services 308, LLC by the Veterans Integrated Service Network 2, a civilian agency. The contract is a delivery order with a firm-fixed price type and an ultimate completion date of September 30, 2026. Optum Infusion Services 308, LLC is a subsidiary of UnitedHealth Group Incorporated, a large, diversified healthcare company that provides a range of services to federal government...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a $1.2M firm fixed-price delivery order to Optum Infusion Services 308, LLC for pharmacy compounding services focused on oncology drugs at the Dallas VA facility in Dallas, Texas. The contract, awarded on November 1, 2025, runs through October 31, 2030, and represents a continuation of specialized pharmaceutical services supporting cancer treatment for veteran patients. This delivery order was issued without a...
- This is a federal contract award for CHEMOTHERAPY COMPOUND SERVICE, awarded by the Veterans Integrated Service Network 2 (VISN 2) to the prime contractor Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, and has a ceiling value of $19,603.80. The contract has an ultimate completion date of November 16, 2026, and was awarded on November 20, 2025. The place of performance is...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, was awarded a delivery order valued at $3,633 for pharmacy compounding services by the Department of Veterans Affairs' Veterans Integrated Service Network 20 (VISN 20). The contract, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by September 30, 2026, following its award date of October 1, 2025. Services will be performed at the contractor's facility in Phoenix,...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a $4,558.20 firm fixed-price delivery order to Optum Pharmacy 801, Inc. (doing business as Avella Of Deer Valley, Inc #038) for compounded chemotherapy base pharmaceutical services. The order, issued on October 1, 2024, with an ultimate completion date of September 30, 2025, represents a task order against a larger indefinite delivery vehicle. No set-aside designation was applied to this award. Optum...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, for the provision of pharmacy chemo compound drug services. The contract has a completion date of September 30, 2021 and a potential value of $199,623.94. The contract was awarded on July 9, 2021 without the use of a set-aside. Optum Pharmacy 601 is the prime contractor responsible for performing...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $500,000 firm fixed-price delivery order to Optum Pharmacy 801, Inc. (doing business as Avella Of Deer Valley, Inc #038) for contingency outsourcing of compounded chemotherapy medications. The award, effective June 30, 2025, with an ultimate completion date of June 29, 2026, represents a non-set-aside contract awarded through full and open competition. Optum Pharmacy 801, Inc., a 503A certified pharmacy...
- This is a $55,205.54 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide custom-dosed chemotherapy IV medications for the VA Baltimore Medical Center. The contract has a performance period through June 30, 2025. This requirement was competed on a full and open basis, without any set-aside designations. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, has...
- Optum Pharmacy 801, Inc., a specialty pharmacy subsidiary of UnitedHealth Group Incorporated, was awarded a Blanket Purchase Agreement (BPA) call contract valued at $200,000 by Veterans Integrated Service Network (VISN) 2 on November 17, 2025, for chemotherapy compounding services at New York Harbor VA Medical Center. The contract, structured as a firm fixed-price arrangement with no set-aside designation, extends through November 16, 2026, and will be performed in Phoenix, Arizona. This award...
- 36C24226D0069Indefinite Delivery Contract
- 36C24226D0069-36C24226N0631Delivery Order
Veterans Integrated Service Network 2 issued a $50,000 delivery order to Optum Infusion Services 308, LLC on August 24, 2026, for compounded chemotherapy drugs with a firm fixed-price structure and an ultimate completion date of September 30, 2026. Place of performance is Chandler, AZ. The order carries no set-aside designation. Optum Infusion Services 308 is a subsidiary of UnitedHealth Group and operates as a prime contractor focused on FDA 503A-compliant pharmaceutical compounding and hazardous chemotherapy preparation services across VA facilities, with no subcontract footprint.
Generated 7/22/26, 11:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.0k | 7/13/26 |